KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Tax Rate (2024 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Tax Rate for 2 consecutive years, with 0.88% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate rose 397.0% year-over-year to 0.88%, compared with a TTM value of 1.32% through Dec 2025, up 354.0%, and an annual FY2025 reading of 1.32%, up 354.0% over the prior year.
  • Tax Rate was 0.88% for Q4 2025 at Biocryst Pharmaceuticals, up from 6.34% in the prior quarter.
  • Across five years, Tax Rate topped out at 95.78% in Q1 2025 and bottomed at 6.34% in Q3 2025.